Acadian Asset Management LLC Vista Gen Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $26,098 - $894,796	186,416 New	186,416 $28,000
Q3 2018 Oct 30, 2018	SELL	$1.23 - $1.49 $19,657 - $23,813	-15,982 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$0.85 - $1.5 $13,584 - $23,973	15,982 New	15,982 $22,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.